Related Experiment Video
Updated: May 18, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Defining a tissue stem cell-driven Runx1/Stat3 signalling axis in epithelial cancer
Cornelia Johanna Franziska Scheitz1, Tae Seung Lee, David James McDermitt
1Department of Molecular Biology and Genetics, Cornell University, Ithaca, NY, USA.
Abstract:
Cancers and tissue stem cells (SCs) share similar molecular pathways for their self-renewal and differentiation. The race is on to identify unique pathways to specifically target the cancer, while sparing normal SCs. Here, we uncover the transcription factor Runx1/AML1, a known haematopoietic and leukaemia factor, albeit dispensable for normal adult SC homeostasis, as being important for some mouse and human epithelial cancers. We implicate Runx1 as a SC-intrinsic gene in mouse hair follicle and oral epithelia by genetic lineage tracing in adulthood. Runx1-expressing SCs, but not other cells that ectopically upregulate Runx1 by injury and inflammation, are at the skin tumour origin. Runx1 loss impairs tumour initiation and maintenance and the growth of oral, skin, and ovarian epithelial human cancer cells. Runx1 stimulates Stat3 signalling via direct transcriptional repression of SOCS3 and SOCS4 and this is essential for cancer cell growth. Thus, Runx1 is a broader epithelial SC and cancer factor than previously recognized, and qualifies as an attractive potential target for both prevention and therapy of several epithelial cancers.
Insights
Runx1, a gene not vital for normal stem cells, drives epithelial cancers by activating Stat3 signaling. Targeting Runx1 offers a potential strategy for cancer prevention and therapy.
Area of Science:
- Molecular Biology
- Cancer Research
- Stem Cell Biology
Background:
- Cancers and tissue stem cells (SCs) share self-renewal and differentiation pathways.
- Identifying cancer-specific targets that spare normal SCs is crucial.
Purpose of the Study:
- To investigate the role of transcription factor Runx1/AML1 in epithelial cancers.
- To determine if Runx1 is a potential therapeutic target for epithelial cancers.
Main Methods:
- Genetic lineage tracing in adult mice to implicate Runx1 in SC-intrinsic gene function.
- Assessing the impact of Runx1 loss on tumor initiation, maintenance, and cancer cell growth.
- Investigating Runx1's mechanism of action on Stat3 signaling.
Main Results:
- Runx1 is essential for some mouse and human epithelial cancers, acting as an SC-intrinsic gene.
- Runx1-expressing SCs, not those with upregulated Runx1 due to inflammation, initiate skin tumors.
- Runx1 loss impairs tumor growth, and Runx1 promotes cancer cell growth by repressing SOCS3/SOCS4, activating Stat3 signaling.
Conclusions:
- Runx1 is a broader epithelial SC and cancer factor than previously understood.
- Runx1 is an attractive target for the prevention and therapy of multiple epithelial cancers.
Related Concept Videos
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Regulation of Angiogenesis and Blood Supply
The Tumor Microenvironment

